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Abstract
Background: Obesity is a risk factor for various types of infectious diseases and cancer. The increase in adipose tissue causes
alterations in both adipogenesis and the production of adipocyte-secreted proteins (adipokines). Since natural killer (NK)
cells are the host’s primary defense against virus-infected and tumor cells, we investigated how adipocyte-conditioned
medium (ACM) affects functions of two distinct human NK cell subsets.
Methods: Isolated human peripheral blood mononuclear cells (PBMCs) were cultured with various concentrations of human
and murine ACM harvested on two different days during adipogenesis and analyzed by fluorescent-activated cell sorting
(FACS).
Results: FACS analyses showed that the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL),
granzyme A (GzmA) and interferon (IFN)-c in NK cells was regulated in a subset-specific manner. ACM treatment altered IFN-
c expression in CD56dim NK cells. The production of GzmA in CD56bright NK cells was differentially affected by the distinct
adipokine compositions harvested at different states of adipogenesis. Comparison of the treatment with either human or
murine ACM revealed that adipokine-induced effects on NK cell expression of the leptin receptor (Ob-R), TRAIL and IFN-c
were species-specific.
Conclusion: Considering the growing prevalence of obesity and the various disorders related to it, the present study
provides further insights into the roles human NK cell subsets play in the obesity-associated state of chronic low-grade
inflammation.
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Introduction
Obesity, defined as a body-mass-index (BMI) $30 kg/m2, is
one of today’s leading health threats in most industrialized
countries [1]. Data from the National Health and Nutrition
Examination Survey (NHANES) 2005–2006 show that more than
34% of the US population aged 20 years and older were obese [2].
Excess body weight is associated with the manifestation of several
disorders, such as type 2 diabetes, cardiovascular disease,
hypercholesterolaemia and hypertension [3]. Furthermore, obesity
increases the susceptibility to infections and the risk to develop
multiple types of cancer (e.g. colon and postmenopausal breast
cancer) [4,5]. These findings led to the suggestion of obesity being
an immunodeficient state [6].
White adipose tissue, which is highly expanded in obesity, acts
as an endocrine organ that actively participates in physiological
and pathological processes, including immunity and inflammation
[7]. Among the secreted adipokines with relevance for immuno-
logical processes are tumor necrosis factor (TNF)-a, interleukin
(IL)-6, leptin, adiponectin, resistin and visfatin [8,9]. Adiponectin’s
influence on immune functions seems to be mainly anti-
inflammatory as it suppresses the production and secretion of
the pro-inflammatory cytokines TNF-a, IL-6 and interferon (IFN)-
c by LPS-activated macrophages, while the anti-inflammatory
cytokines IL-10 and IL-1 receptor antagonist are induced in
adiponectin-treated monocytes, macrophages and dendritic cells
[10,11]. Leptin, resistin and visfatin are considered pro-inflam-
matory adipokines. They induce pro-inflammatory cytokines
[12,13] and their plasma concentrations are elevated during
inflammatory conditions [14]. Plasma leptin is elevated during
obesity [15], and cells of both the innate and adaptive immunity
are influenced by leptin [16]. Leptin-deficient children have been
reported to suffer more often from infections than their healthy
siblings and to show impaired numbers and function of T cells
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[17], thus implicating a role for leptin as a link between nutritional
and immunological status of the organism. Previous in vitro and
in vivo studies conducted by our group demonstrated an impaired
leptin-dependent signal transduction in natural killer (NK) cells in
diet-induced obesity (DIO) which could be ameliorated by transfer
of NK cells to a normal-weight metabolic environment [18,19].
NK cells are an integral component of the innate immune
system. They produce cytokines (e.g. IFN-c) that stimulate other
immune cells and they destroy infected or transformed cells [20].
NK cells express a variety of activating and inhibitory receptors
which determine their specificity for divergent targets [21].
Adiponectin is a negative regulator of IL-2-induced NK cell
cytotoxicity and of IFN-c production by NK cells [22]. The effects
of a composition of adipocyte-derived factors on NK cell
immunity, however, remain unclear. NK cells are the central
active component of the host’s immune system in the early phase
of cancer development and metastasis. Since adipokines have been
suggested to represent a possible link between obesity and cancer
[23], a detailed investigation on the influence of adipokines on
human NK cell functions is warranted. The aim of the present
study was to show how adipocyte-derived proteins may contribute
to a compromised immune response during obesity by systemat-
ically analyzing effects of human SGBS and murine 3T3-L1
adipocyte-conditioned medium (ACM) on human NK cell subsets.
The SGBS cell strain was established from a subcutaneous
adipose tissue sample of a male infant with Simpson-Golabi-
Behmel (SGBS) syndrome. It is utilized as an in vitro model for
human adipocyte differentiation and shows a protein secretion




Leukocyte filters were obtained shortly after processing of blood
donations from healthy donors. Since the study is an investigation
of anonymous blood probes no written or verbal consent was
provided. For this study a formal written waiver (issued by the
head of the ethics committee Professor Tro¨ger) was obtained from
the ethics committee. All research was performed at the Hannover
Medical School.
For the stimulation with each of the different ACM, six
leukocyte preparations were made out of six filters. The samples
were categorized according to the BMI of the blood donors into
two groups: three normal-weight (nw, BMI ,25 kg/m2) and three
overweight (ow, BMI $25 kg/m2). In the nw group used for
stimulation with SGBS ACM harvested on day 7 the BMI range
was 20–24 with a mean age of 52 years and in the corresponding
ow group the BMI range was 25–29 with a mean age of 55 years.
In the nw group used for stimulation with SGBS ACM from day
11 the BMI range was 18–24 with a mean age of 43 years and the
corresponding ow group had a BMI range of 25–28 with a mean
age of 44 years. The PBMCs stimulated with 3T3-L1 ACM
harvested on day 7 were derived from three nw (BMI range 20–24,
mean age 43 years) and three ow (BMI range 25–27, mean age 56
years) blood donors to match the samples stimulated with the
SGBS ACM from day 7.
PBMC Isolation and Culture
PBMCs were isolated from leukocyte filters used for the
preparation of erythrocyte concentrates. Filters were obtained
from the Institute for Transfusion Medicine, Hannover Medical
School, shortly after blood passage and flushed with phosphate-
buffered saline (PBS) (Dulbecco, Pasching, Austria) in the opposite
direction of original blood flow. The extracted leukocytes were
separated by density gradient centrifugation for 20 minutes at
10006g and 4uC using biocoll separating solution (Biochrom AG,
Berlin, Germany). PBMCs from the interphase were washed with
PBS for 10 minutes at 10006g and 4uC and for another 10
minutes at 4006g and 4uC, resuspended in RPMI-1640 medium
supplemented with 10% fetal calf serum (FCS), 100 U/ml
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and
1 mM sodium pyruvate (Biochrom AG) (R10-medium) and
adjusted to 26106 cells/ml. The PBMCs were cultured in 96-
well round-bottom cell culture plates (Greiner Bio-One GmbH,
Solingen, Germany) (56105 cells/well) in R10-medium supple-
mented with 100 iu/ml Interleukin-2 (IL-2) (Eurocetus, Amster-
dam, the Netherlands) at 37uC in a humidified atmosphere with
5% CO2.
SGBS Adipocyte-conditioned Medium
SGBS preadipocytes were seeded at a density of 4000 cells/cm2
and grew to 80% confluence in adipocyte growth medium
(DMEM medium plus 10% FBS, Invitrogen, Karlsruhe, Ger-
many, supplemented with 300 mM biotin, 150 mM panthothenat,
100 U/ml penicillin and 100 mg/ml streptomycin, all from Sigma-
Aldrich, Seelze, Germany). To initiate adipogenic differentiation,
cells were washed with PBS and incubated for three days with
adipogenesis medium 1 (adipocyte growth medium as above
without FBS plus 20 mM insulin, 0.2 nM triiodothyronine,
0.01 mg/ml human transferrin, 500 mM IBMX, 0.25 nM dexa-
methasone and 10 mM pioglitazone, all from Sigma-Aldrich,
Figure 1. Cytospots prepared with human peripheral blood
mononuclear cells (PBMCs) isolated from leukocyte filters or
heparinized blood showed no morphological differences in the
lymphocytes resulting from the preparation techniques. A)
PBMCs isolated from a leukocyte filter. The left cell displays an NK cell
expressing CD56 (red) and the leptin receptor (Ob-R, blue). The
hematoxylin stained lymphocyte (right) is negative for CD56 and Ob-R.
B) The representative cytospot prepared with PBMCs isolated from
heparinized blood shows a CD56/Ob-R double-positive NK cell (top), a
CD56-positive lymphocyte (middle) and a double-negative lymphocyte
counterstained in hematoxylin.
doi:10.1371/journal.pone.0075703.g001
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Seelze, Germany). At day four, medium was changed to
adipogenesis medium 2 (adipocyte growth medium as above
without FBS plus 20 mM insulin, 0.2 nM triiodothyronine and
0.01 mg/ml human transferrin). To obtain adipocyte-conditioned
medium, we collected the supernatants at days 7 and 11,
centrifuged the supernatants at 50006g for 10 minutes and
collected the ACM without transferring any cellular debris. ACM
was stored at 280uC and sterile-filtered before use.
3T3-L1 Adipocyte-conditioned Medium
3T3-L1 cells were grown in DMEM high glucose (GibcoH,
Invitrogen Carlsbad, CA) with 10% bovine calf serum (Hyclone,
Thermo Fisher Scientific, Waltham, MA). Two days after
confluence differentiation was induced with 800 nM insulin,
1 mM dexamethason and 0.5 mM 3-isobutyl-1-methylxanthine
in DMEM high glucose with 10% FBS (Atlas Biological, Fort
Collin, CO) for three days, followed by two days with 800 nM
insulin and 1 mM dexamethason. ACM was collected at days 7
and 11 after induction, stored at 280uC and sterile-filtered before
use.
Cell Stimulation
PBMCs were stimulated directly after isolation or after one or
two days in culture with either SGBS or 3T3-L1 ACM harvested
on day 7 or 11 after the induction of adipogenic differentiation (as
described above). Portions of 1% of the PBMC culture medium
were substituted with either SGBS or 3T3-L1 ACM harvested on
one of the respective days and 100 U/ml IL-2 (Eurocetus) was
supplemented. In cases where intracellular staining for cytokines
was performed, brefeldin A (2 mg/ml; Sigma-Aldrich, Seelze,
Germany) was added 1 h after the beginning of cell stimulation to
inhibit cytokine secretion. Cells were cultivated with the condi-
tioned medium for 24 hours at 37uC in a humidified atmosphere
with 5% CO2. A well of cells treated with R10-medium plus IL-
served as control.
Cytospot Preparation and Immunohistology
PBMCs were isolated from either leukocyte filters or from
heparinized blood. The heparinized blood samples were also
subjected to density gradient centrifugation and PBMCs extracted
from the interphase as described above. Afterwards, the cells were
maintained in R10-medium. Cells were washed with PBS for 10
minutes at 4006g and 4uC, adjusted to 7506103/ml in
autoMACSTM Rinsing Solution (Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany) and 100 ml were applied per spot on
SuperFrostHPlus microscope slides (Menzel-Gla¨ser, Braunschweig,
Germany) and centrifuged for 5 minutes at 4006g in a Shandon
Cytospin3 centrifuge (Life Sciences International Ltd, Cheshire,
England). The cytospots were air-dried for 2 hours and preserved
at 220uC until staining. The unthawed preparations were
immersion fixed with methanol-acetone (1:1) for 10 minutes,
rehydrated with tris-phosphate buffered saline (TBS)-Tween (1:5;
Serva, Boehringer Ingelheim, Germany) and afterwards incubated
with the primary mouse anti human antibody directed against the
leptin receptor Ob-R (sc-8391; Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany; dilution 1:100 in PBS 1 M, 1% BSA
(Serva, Heidelberg, Germany), 0.1% Na-azide (Merck, Darmstadt,
Germany) (measuring buffer)) overnight at 4uC in a humid
chamber. After rinsing in TBS-Tween, cytospots were incubated
with rabbit anti mouse immunoglobulins (Z259; 1:50; DakoCyto-
mation, Glostrup, Denmark) supplemented with 5% Pentaglobin
([,76%IgG, ,12% IgM, ,12% IgA], Biotest Pharma GmbH,
Dreieich, Germany) to prevent non-specific binding via Fc
receptors. To visualize the binding, the APAAP-complex (mono-
clonal mouse antibodies D651; 1:50 in TBS for 30 minutes;
DakoCytomation) was utilized, followed by the repetition of the
last two steps for 15 minutes. The cytospots were stained with Fast
Blue (Fast Blue BB Salt, Sigma-Aldrich, St. Louis, USA) for 25
minutes, washed with TBS-Tween and incubated with a second
primary mouse anti human antibody directed against CD56 (clone
NCAM16.2;BD Biosciences, Heidelberg, Germany; dilution
1:7500 in measuring buffer) for 30 minutes. After rinsing in
TBS-Tween, APAAP-labeling was repeated as described above
and cytospots were stained with Fast Red (Fast Red TR Salt,
Sigma-Aldrich) for 25 minutes, counterstained with hematoxylin
(1:5 in PBS; Mayer’s hemalaun solution, Merck, Darmstadt,
Germany) for 30 seconds and mounted in glycergel (DakoCyto-
mation). Method specificity was tested by omission of the primary
antibodies. Light microscopy was performed with an Axiophot
microscope (Carl Zeiss) to qualitatively analyze possible morpho-
logical alterations in the NK cells isolated from leukocyte filters as
compared to cells extracted from heparinized blood. As depicted
in Figures 1A and 1B no morphological difference resulted from
the cell preparation technique.
Phenotypic Analyses
For phenotypic analyses after 24 hours of stimulation (as
described above), PBMCs were stained with the directly labelled
monoclonal mouse-anti human antibodies CD3 conjugated with
phycoerythrin (PE)-Cy7 (CD3-PE-Cy7) (clone SK7, 1:50), CD56
conjugated with allophycocyanin (CD56-APC) (clone NCAM16.2,
1:100), CD253-PE (TRAIL; clone RIK-2, 1:20) (BD Biosciences,
San Diego, CA) and anti-hLeptin R (Ob-R) conjugated with
carboxyfluorescein (anti-hLeptin R-CFS) (clone # 52263, 1:20)
(R&D Systems, Wiesbaden, Germany). PBMCs (56105 cells/
100 ml) were incubated in 96 well-round bottom plates with the
Table 1. Lymphocyte numbers after 24 hours of stimulation with ACM (adipocte-conditioned medium).
Medium SEM 0.1% ACM SEM 1% ACM SEM 10% ACM SEM
NK cells 13.1 2.2 14.1 3.6 14.3 3.7 14.1 3.6
CD56dim NK cells 93.2 1.0 93.3 1.4 92.9 1.4 92.7 1.8
CD56bright NK cells 6.8 1.0 6.7 1.5 7.1 1.4 7.3 1.8
T cells 59.9 3.0 60.8 2.9 60.9 3.1 61.2 2.8
NKT cells 3.4 1.0 2.4 0.7 2.3 0.7 2.4 0.7
Human peripheral blood mononuclear cells (PBMCs) were isolated from six leukocyte filters and cultured for 24 hours with R10-medium conditioned with 0.1%, 1% or
10% of SGBS ACM. PBMCs incubated for 24 hours with medium only served as controls. A detailed description of the incubation procedure can be found in the materials
and methods section. NK cells, T cells and NKT cells are shown as percent of lymphocytes. CD56dim and CD56bright NK cells are shown as percent of all NK cells.
doi:10.1371/journal.pone.0075703.t001
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above mentioned antibodies for 20 minutes at 4uC, washed twice
with measuring buffer and analyzed by flow cytometry using a
FACSCanto (BD Biosciences, San Jose, CA) with FACS Diva
software v5.0.3. A well with cells stained with the above mentioned
Figure 2. Ob-R (leptin receptor) expression after ACM stimulation. Human peripheral blood mononuclear cells (PBMCs) isolated from six
leukocyte filters in each case were cultured for 24 hours with R10-medium conditioned with 1% of SGBS ACM harvested on day 7 or day 11 after
induction of adipogenic differentiation. PBMCs incubated for 24 hours with medium only served as controls. A detailed description of the incubation
procedure can be found in the materials and methods section. A) Ob-R-expressing human blood NK cells as percentage of human blood NK cells; B)
Ob-R-expressing human blood CD56dim NK cells as percentage of human blood CD56dim NK cells; C) Ob-R-expressing human blood CD56bright NK
cells as percentage of human blood CD56bright NK cells. D) Ob-R-expressing human blood NK cells as percentage of human blood NK cells from lean
(nw, BMI,25, n = 3) and overweight (ow, BMI$25, n = 3) humans after 24 hours of stimulation with 1% SGBS ACM harvested on day 7 after induction
of adipogenesis, controls were incubated for 24 hours with medium only. All data represent means+SEM.
doi:10.1371/journal.pone.0075703.g002
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antibodies except for anti-hLeptin R-CFS served as control for the
measurements of Leptin R.
Intracellular Staining
After 24 hours of cell culture and another 24 hours of
stimulation (as described above) the expression of intracellular
cytokines by NK cells was analyzed using a FACSCanto
cytometer. Prior to intracellular labelling cell surface staining
was performed. PBMCs (56105 cells/100 ml in 96-well round-
bottom plates) were stained with CD3-PE (1:250) and CD56-APC
(1:100). After 20 minutes at 4uC, cells were washed twice with
measuring buffer and incubated with PBS supplemented with 4%
paraformaldehyde (Merck, Darmstadt) in the dark for 10 minutes
at room temperature. Cells were washed once with measuring
buffer and once with saponin buffer (aqua dest. supplemented with
0.1% saponin and 0.01 M HEPES), then resuspended in saponin
buffer and stained with the directly labelled mononuclear mouse
anti-human antibodies granzyme A (GzmA) conjugated with
fluorescein isothiocyanate (GzmA-FITC) (clone CB9, 1:100) and
IFN-c-PE-Cy7 (clone 4 S.B3, 1:100) (both BD Biosciences). To
prevent non-specific binding via Fc receptors, each well was
supplemented with 5 ml Pentaglobin. The data from flow
cytometric analyses were processed with FACS Diva software
v5.0.3. A well with cells stained with the above mentioned
antibodies except for IFN-c-PE-Cy7 served as control for the
measurements of IFN-c expression by NK cells.
Figure 3. TRAIL expression after ACM stimulation. Human peripheral blood mononuclear cells (PBMCs) were isolated from six leukocyte filters
in each case and cultured for 24 hours with R10-medium conditioned with 1% of SGBS ACM harvested on day 7 or day 11 after induction of
adipogenesis. PBMCs incubated for 24 hours with medium only served as controls. A detailed description of the incubation procedure can be found
in the materials and methods section. A) TRAIL-expressing human blood NK cells as percentage of human blood NK cells; B) TRAIL-expressing human
blood CD56dim and CD56bright NK cells as percentage of human blood CD56dim and CD56bright NK cells. Statistically significant differences between
the numbers of TRAIL expressing CD56dim and CD56bright NK cells are depicted with an asterisk (*). All data represent means+SEM.
doi:10.1371/journal.pone.0075703.g003
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Conjugate-forming Assay
After two days of culture and 24 hours of stimulation (as
described above), cell surface staining of the PBMCs (56105 cells/
100 ml) was performed in 96-well round-bottom plates by adding
CD3-PE (1:250) and CD56-APC (1:100) and incubating for 20
minutes at 4uC. After two washes, each well was supplemented
with 86104 cells of the K562 erythroleukemia line (which were
maintained in suspension culture flasks at 37uC in a humidified
atmosphere with 5% CO2) and replenished with R10-medium up
to a total volume of 240 ml. The cells were lightly centrifuged at
1006g for 3 minutes at 4uC and incubated for 20 minutes at 37uC,
5% CO2 and 85% RH. Cells were carefully resuspended and
transferred into FACS tubes using pipet tips with expanded
apertures. After gently mixing the cells, conjugate formation was
analyzed using a FACSCanto by gating on PBMC and K562 cells,
excluding CD3+ T cells.
K562 cells display a green autofluorescence which was detected
in the FL1 channel. By gating on clusters fluorescing green
(autofluorescence) and blue (CD56-APC) simultaneously, NK cells
bound to K562 target cells could be identified.
Statistics
Data are expressed as means+SEM. Significance was assigned
when p,0.05. Data sets were analyzed using one-way ANOVA
with Tukey multiple comparison test for post hoc analysis. The
software used was with StatView Version 5.0, SAS Institute Inc.,
Cary, NC.
Results
Human peripheral blood mononuclear cells (PBMCs) were
cultured for 24 hours with R10-medium conditioned with 1% of
SGBS ACM harvested on day 7 (d7) or day 11 (d11) after
induction of adipogenesis. For each of the two different ACM
treatments six different leukocyte preparations were analyzed.
PBMCs incubated for 24 hours with medium only served as
controls. Here we mainly show results after stimulation with ACM
Figure 4. Ability of human blood NK cells to form conjugates with cells of the K562 erythroleukemia line after ACM stimulation.
Human peripheral blood mononuclear cells (PBMCs) isolated from six leukocyte filters in each case were cultured for 24 hours with R10-medium
conditioned with 1% of SGBS ACM harvested on day 7 or day 11 after induction of adipogenic differentiation. PBMCs incubated for 24 hours with
medium only served as controls. A detailed description of the incubation procedure can be found in the materials and methods section. A) About
30% of the NK cells (CD32CD56+) were able to form conjugates with K562 target cells (upper right quadrant) irrespective of the cultivation
conditions. B) Conjugate forming human blood NK cells as percentage of human blood NK cells. All data represent means+SEM.
doi:10.1371/journal.pone.0075703.g004
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harvested on day 7 when stimulation with the two different ACM
lead to comparable findings. Incubation with medium only and
incubation with 50% R10-medium and 50% fresh adipogenesis
medium 2 (that has not been used to culture SGBS cells and
therefore does not contain adipokines) led to comparable results
(data not shown). All significant differences shown after ACM
stimulation versus incubation with medium only were also seen
after comparison of ACM stimulation with incubation with 50%
R10-medium and 50% adipogenesis medium 2. Therefore we
could exclude that effects after ACM stimulation were influenced
by supplements to the adipogenesis medium such as e.g.
triiodothyronine.
Figure 5. IFN-c and GzmA expression after ACM stimulation. Human peripheral blood mononuclear cells (PBMCs) isolated from six leukocyte
filters in each case were cultured for 24 hours with R10-medium conditioned with 1% of SGBS ACM harvested on day 7 (d7) or day 11 (d11) after
induction of adipogenesis. PBMCs incubated for 24 hours with medium only served as controls. A detailed description of the incubation procedure
can be found in the materials and methods section. A) IFN-c-expressing human blood CD56dim and CD56bright NK cells as percentage of human blood
CD56dim and CD56bright NK cells treated with 1% of the ACM harvested on day 7 after induction of adipogenic differentiation; B) GzmA-expressing
human blood CD56dim NK cells as percentage of human blood CD56dim NK cells treated with 1% of the ACM harvested on day 7 or 11 after induction
of adipogenic differentiation; C) GzmA-expressing human blood CD56bright NK cells as percentage of human blood CD56bright NK cells treated with
1% of the ACM harvested on day 7 or 11 after induction of adipogenic differentiation; Statistically significant differences between the stimulation
with SGBS ACM and the medium control are depicted with an asterisk (*). Statistically significant differences between the stimulation with SGBS ACM
harvested on day 7 after induction of adipocyte differentiation and the same dosage of SGBS ACM harvested on day 11 after induction of adipogenic
differentiation are depicted with a rhomb (#). Statistically significant differences between the numbers of IFN-c expressing CD56dim and CD56bright
NK cells are depicted with a paragraph sign (1). All data represent means+SEM.
doi:10.1371/journal.pone.0075703.g005
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Lymphocyte Numbers are not Altered After 24 Hours of
ACM Stimulation
After 24 hours of SGBS ACM stimulation, cell numbers were
not significantly changed as compared to the medium control.
Independent of the treatment conditions the proportions of NK
cells, T cells and NKT cells as percentage of lymphocytes
remained comparable, as did numbers of CD56dim and CD56bright
NK cells as percentage of all NK cells (Table1).
Expression of the Leptin Receptor is Comparable in Both
Human NK Cell Subsets Before and After ACM
Stimulation
In a previous study we could show that blood NK cells from
DIO rats show a significant up-regulation of the leptin receptor
isoform Ob-Rb in comparison to lean littermates [19]. Thus, we
investigated the effect of a 24 hours stimulation with human SGBS
ACM on the Ob-R expression of human peripheral blood NK
cells. About 4–8% of the NK cells expressed Ob-R (Fig.2A). The
two NK cell subgroups showed a comparable Ob-R expression
pattern (Fig.2B, C). Comparison of the Ob-R expression patterns
of NK cells from overweight (n = 3) and normal-weight subjects
Figure 6. Ob-R, TRAIL and IFN-c expression after stimulation with either murine or human ACM. PBMCs were cultured for 24 hours with
R10-medium conditioned with 1% of either murine 3T3-L1 or human SGBS ACM harvested on day 7 after induction of adipocyte differentiation.
PBMCs incubated for 24 hours with medium only served as controls. A detailed description of the incubation procedure can be found in the materials
and methods section. A) Ob-R-expressing human blood NK cells as percentage of human blood NK cells; B) TRAIL-expressing human blood NK cells as
percentage of human blood NK cells; C) IFN-c-expressing human blood NK cells as percentage of human blood NK cells. Statistically significant
differences between the stimulation with 3T3-L1 or SGBS ACM and the medium control are depicted with an asterisk (*). Statistically significant
differences between the stimulation with SGBS ACM and 3T3-L1 ACM are depicted with a rhomb (#). All data represent means+SEM.
doi:10.1371/journal.pone.0075703.g006
Adipokines Differentially Affect Human NK Cells
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(n = 3) showed a tendency towards higher numbers of Ob-R-
positive NK cells in the blood of overweight individuals (Fig.2D).
TRAIL Expression is Higher in CD56bright than in CD56dim
NK Cells
Flow cytometric examination of the cell surface expression of
TRAIL on human peripheral blood NK cells revealed that,6.2%
of all NK cells expressed TRAIL (Fig.3A, B). Stimulation with
SGBS ACM did not significantly affect the TRAIL expression.
Independently from cultivation conditions, CD56bright NK cells
expressed TRAIL six times more than CD56dim (Fig.3A, C).
NK Cell Ability to Form Conjugates with Target Cells is
not Altered After ACM Stimulation
In order to study the direct interaction between NK cells and
NK-sensitive target cells after 24 hours of SGBS ACM stimulation,
PBMC stimulation was followed by incubation with cells from the
erythroleukemia line K562 for 20 minutes. The subsequent flow
cytometric analysis revealed that ,30% of the NK cells were able
to form conjugates with K562 cells (Fig. 4). SGBS ACM did not
significantly alter the conjugate-forming ability of NK cells. We
also found no difference between CD56dim and CD56bright NK cell
populations concerning their ability to form conjugates with K562
cells.
ACM Stimulation Distinctly Influences the Expression of
Intracellular Cytokines in NK Cell Subsets
FACS analyses of the effect of a 24 hours SGBS ACM
stimulation on the expression of intracellular IFN-c by NK cells
revealed that the CD56bright NK cells showed a threefold higher
IFN-c expression as compared to the CD56dim NK cell subset
(Fig.5A). Additionally, the ACM stimulation lead to an increase in
the IFN-c expressing cells in the CD56dim NK cell subset, whereas
the already high IFN-c expression level of the CD56bright NK cells
remained unchanged.
A difference in the stimulatory effects of the two ACM harvested
on different days was seen regarding GzmA production by NK
cells. The numbers of both NK cell subsets significantly increased
after treatment with the ACM harvested on day 11 versus
treatment with the day 7 ACM (Fig.6B+C). Culturing of the
PBMCs with 1% of the day 7 ACM led to a significant decrease of
the GzmA-expressing CD56dim NK cells (Fig.5B). In contrast,
after stimulation with the day 11 ACM an increase of GzmA-
positive CD56bright NK cells could be observed (Fig.6C).
ACM-induced Effects on the Expression of Ob-R, IFN-c
and TRAIL in NK Cells are Species-specific
The human SGBS adipocyte strain was introduced ten years
ago and has consecutively been shown to be comparable to
primary human adipocytes in its gene expression profile during
differentiation [24]. The murine 3T3-L1 cell line has been a well
established model for the in vitro examination of adipogenesis and
the secretory functions of adipocytes for a long time [25,26]. Since
species-specific differences between human and murine adipokines
become more and more evident [27], we tested the species-
specificity of our stimulation assay by repeating selected experi-
ments with ACM of SGBS and 3T3-L1 adipocytes to compare the
effects of human and murine ACM on NK cell functions. The
ACM had both been collected on day 7 of adipogenesis, and in
each case PBMCs isolated from six different leukocyte filters were
cultured for 24 hours in R10-medium conditioned with either
SGBS or 3T3-L1 ACM. FACS analyses were performed to
determine the expression of Ob-R, TRAIL and IFN-c expression.
After treatment with the 3T3-L1 ACM, numbers of NK cells
expressing Ob-R or IFN-c were not altered as compared to the
medium control (Fig.6A, C). The levels of Ob-R+ NK cells were
significantly higher after treatment with SGBS ACM as compared
to the treatment with the murine 3T3-L1 ACM. While culturing
of the PBMCs with the human ACM did not affect the TRAIL
expression of NK cells, addition of the murine ACM led to a
decrease in the number of TRAIL-positive NK cells (Fig.6B).
The number of IFN-c-expressing NK cells was significantly
higher after treatment with the SGBS ACM in comparison to the
IFN-c expression of cells treated with 3T3-L1 ACM or medium
only (Fig.6C).
Discussion
The present study was conducted to investigate the influence of
an obese metabolic microenvironment on human peripheral blood
NK cells. According to the density of their surface expression of
CD56, human NK cells can be subdivided into two distinct
subsets: CD56dim and CD56bright NK cells [28]. Our analyses
showed that the intracellular cytokine production of NK cells and
cell surface marker expression were influenced subset-specifically
after stimulation with a heterogeneous cocktail of human
adipokines.
The CD56bright NK cell subset is assumed to act mainly via
immunomodulatory actions, being the subset type which primarily
secretes IFN-c [28]. We observed that a significantly higher
amount of the CD56bright NK cells expressed intracellular IFN-c
as compared to the CD56dim NK subset. Moreover, the
proportion of cells expressing the death ligand TRAIL was 6-
fold higher in the CD56bright subset than in the CD56dim NK cells.
So far, little is known about differences between the two human
NK cell subsets regarding their TRAIL expression pattern.
TRAIL is constitutively expressed in human and murine liver
NK cells [29,30]. In humans, one report noted the majority of
TRAIL to be expressed in the CD56bright subset of NK cells in
patients with chronic hepatits B [31]. As a subpopulation of
murine NK cells was shown to express TRAIL as a result of the
autocrine production of IFN-c [30,32], the greater occurrence of
TRAIL+ cells in the CD56bright compared to the CD56dim NK
cells could also be explained by a higher expression of IFN-c in
these cells. While the higher amount of IFN-c-positive CD56bright
NK cells was independent from culturing conditions, the initially
lower proportion of IFN-c-expressing cells seen in the CD56dim
NK subset was increased after stimulation with ACM. In earlier
investigations from our group a higher IFN-c production of NK
cells was seen after short-term (18 h) leptin treatment [33]. Long-
term leptin stimulation, on the other hand, led to a decreased IFN-
c production by NK cells. Taking our present findings into
consideration, it seems that this early increase in IFN-c production
is due to a higher IFN-c expression by the CD56dim NK cell
subset. This is further supported by a report that observed a
subset-specifically regulated IFN-c production by NK cells upon
receptor mediated stimulation. CD56dim NK cells produced IFN-c
in the early phase of stimulation, while the long-term IFN-c
production is performed by the CD56bright NK cell subset [34].
Adipose tissue is highly dynamic and adipocyte turnover occurs
constantly in human adults with a replacement rate of about 10%
of the fat cells per year [35]. The increase in adipose tissue mass
during obesity results from both hypertrophic and hyperplastic
growth [36]. It has been proposed to go along with adipose tissue
dysfunction in terms of impaired adipogenesis and aberrant
secretion patterns [37,38], consequently resulting in changing
circulating levels of adipokines [39].
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The collection of ACM we utilized in our experiments was
conducted on two different days of adipogenic differentiation.
Thus they contain different concentrations and types of adipokines
due to the respective secretory ability of SGBS adipocytes at the
particular point of time during adipogenesis. SGBS adipocytes
have been shown to be morphologically, biochemically and
functionally identical to in vitro differentiated adipocytes from
healthy human subjects. Their pattern and time-course of gene
expression during differentiation was comparable to the findings in
human preadipocytes in primary culture [24]. SGBS cells show a
dynamic secretion pattern dependent of their state of differenti-
ation [27,39]. Though the majority of adipocyte secreted proteins
(including leptin and adiponectin) is increasingly produced over
the time span of adipocyte differentiation, the secretion levels of a
minor fraction either decrease consistently or show a midterm
peak level [24,27]. Interestingly, the presence of the two ACM
harvested on different days influenced the IFN-c expression in NK
cells similarly, whereas the expression of the cytotoxic enzyme
GzmA was affected distinctly by each of the two different ACM.
Stimulation with 1% of the ACM harvested on day 7 decreased
the percentage of GzmA producing NK cells. Contrastingly, the
same dosage of the day 11 ACM led to an increase in the GzmA
expression in the CD56bright NK cells without having this effect on
the CD56dim NK cells.
The most extensively studied adipokine is leptin and it affects
immune cell functions via its receptor Ob-R [40] which is also
expressed by human NK cells [41]. Our results show a similar
distribution of Ob-R+ cells in both NK cell subsets with 4–8% of
the cells expressing the leptin receptor. We observed slightly
higher levels of Ob-R+ NK cells in overweight subjects (BMI
$25 kg/m2) as compared to normal-weight subjects (BMI
,25 kg/m2), consistent with a previous study that showed higher
leptin receptor mRNA levels in DIO rats in comparison to lean
littermates [19]. After an intravenous leptin injection, the Ob-Rb
expression in NK cells from obese rats was up-regulated. This
occurred together with a decreased NK cell activity and a lower
activation of Ob-Rb postreceptor signaling components, suggest-
ing a functional desensitization of leptin signaling in NK cells of
obese animals. In a more recent study by our group an up-
regulated Ob-R expression after leptin stimulation was also seen in
human NK cells [33].We further noted a trend of higher
peripheral blood NK cell numbers in the overweight group as
compared to the normal-weight group. Our group previously
showed higher NK cell numbers in DIO rats after adoptive
transfer from obese rats as compared to lean recipients [18].
Studies concerning adipocyte differentiation and adipokine
secretion have frequently been conducted with the well-established
murine adipocyte cell line 3T3-L1 [25,26]. However, the
extrapolation of findings from these experiments to the human
system is limited by the fact that adipokines show species-specific
differences [27,39]. The poor comparability of findings in humans
and mouse models was recently confirmed by a study investigating
the effects of inflammation on white blood cell gene expression
[42]. Our studies showed distinct effects of human SGBS and
murine 3T3-L1 ACM on NK cells. Thus, we suggest that the
species-specificity of adipokine-immune interactions should also be
considered in future studies.
Summing up, our results showed that human NK cell functions
were altered after a 24 hours stimulation with human ACM. Our
findings are in line with several studies reporting altered NK cell
functions in obesity or after treatment with the adipokines leptin or
adiponectin [18,19,22,41,43,44]. Here, we could show that the
in vitro exposition of PBMCs to an obese metabolic milieu
differentially influenced the expression of intracellular IFN-c and
GzmA in the two distinct human NK cell subsets. Both cytokines,
IFN-c and GzmA, have been associated with autoinflammatory
diseases. The relation between altered adipokine levels during
obesity and associated autoimmune proinflammatory conditions,
as seen in type 2 diabetes, is subject to extensive research. Our
study gives further reference to the mechanisms by which human
NK cell subsets may contribute to the chronic low-grade
inflammatory state observed during obesity.
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